JeanLuc Fleurial - UCB SA President
| UCB Stock | EUR 174.15 4.25 2.50% |
President
Mr. JeanLuc Fleurial has served as Executive Vice President, Chief Talent Officer, Member of the Executive Committee of UCB S.A. since 2017. EXPERIENCE Over 20 years of experience in building and implementing talent strategy across geographies and businesses, mainly with ProcterGamble and Bristol Myers Squibb. He is passionate about people and organization development, building inclusive and innovative culture and is inspired every day by the mission to help patients. Having recently joined UCB, JeanLuc is highly energized to have the opportunity to contribute to UCBs Patient Value Strategy, and is delighted to support the development of a company culture and talent strategy that will bring even more innovative medicines to meet patients unmet needs. Key dates in JeanLucs career 2017 Joins UCB as Chief Talent Officer He also heads UCBs Global Communications and Company Reputation department, and the Corporationrationrate Societal Responsibility team. Prior to UCB 2008 17 Various positions at BristolMyers Squibb, including Vice President, Human Resources, US commercial, World Wide Commercialization, Policy and Operations 1998 8 Various positions at Procter Gamble in Europe, making a professional move from Manufacturing to Human Resources after 5 years and supporting different consumer businesses in France and Nordic countries. Education JeanLuc received a Master degree from Chemical Engineering School of Nancy of NancyUniversite, is a qualified executive coach and MBTI practitioner. since 2017.
| Age | 58 |
| Tenure | 7 years |
| Phone | 32 2 559 99 99 |
| Web | https://www.ucb.com |
UCB SA Management Efficiency
The company has return on total asset (ROA) of 0.0468 % which means that it generated a profit of $0.0468 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1069 %, meaning that it generated $0.1069 on every $100 dollars invested by stockholders. UCB SA's management efficiency ratios could be used to measure how well UCB SA manages its routine affairs as well as how well it operates its assets and liabilities.Management Performance
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0468 |
UCB SA Leadership Team
Elected by the shareholders, the UCB SA's board of directors comprises two types of representatives: UCB SA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of UCB. The board's role is to monitor UCB SA's management team and ensure that shareholders' interests are well served. UCB SA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, UCB SA's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sandrine CFA, Ex CFO | ||
| Emmanuel Caeymaex, Executive Vice President Immunology - Patient Value Unit Head | ||
| William Silbey, Exec Counsel | ||
| Pr LowFriedrich, Chief VP | ||
| Charl Zyl, Executive Vice President Head of Patient Value Operations, Member of the Executive Committee | ||
| Kirsten LundJurgensen, Ex Solutions | ||
| Caroline Vancoillie, Chief Functions | ||
| JeanLuc Fleurial, Executive Vice President Chief Talent Officer, Member of the Executive Committee | ||
| JeanChristophe Tellier, Chairman of the Executive Committee, CEO |
UCB Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is UCB SA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0468 | |||
| Profit Margin | 0.15 % | |||
| Operating Margin | 0.19 % | |||
| Current Valuation | 15.81 B | |||
| Shares Outstanding | 189.96 M | |||
| Shares Owned By Insiders | 38.03 % | |||
| Shares Owned By Institutions | 40.78 % | |||
| Price To Earning | 17.19 X | |||
| Price To Book | 1.55 X |
Pair Trading with UCB SA
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if UCB SA position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in UCB SA will appreciate offsetting losses from the drop in the long position's value.Moving against UCB Stock
The ability to find closely correlated positions to UCB SA could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace UCB SA when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back UCB SA - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling UCB SA to buy it.
The correlation of UCB SA is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as UCB SA moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if UCB SA moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for UCB SA can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for UCB Stock Analysis
When running UCB SA's price analysis, check to measure UCB SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy UCB SA is operating at the current time. Most of UCB SA's value examination focuses on studying past and present price action to predict the probability of UCB SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move UCB SA's price. Additionally, you may evaluate how the addition of UCB SA to your portfolios can decrease your overall portfolio volatility.